Søren T. Hoff

4.2k citations

35 papers · 2.7k indexed · 2 hit papers · h-index 19

Impact in

Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immunodeficiency and Autoimmune Disorders
- T-cell and B-cell Immunology

Papers in

Infectious Diseases 25
- Tuberculosis Research and Epidemiology 24
Immunology 15
- Immunodeficiency and Autoimmune Disorders 9

Co-authors: Peter Andersen Mario Roederer Robert A. Seder Ross Lindsay Barbara J. Flynn Steven G. Reed Dylan Davey Patricia A. Darrah
Journals: PLoS ONE (6 papers)Vaccine (5 papers)Tuberculosis (3 papers)European Respiratory Journal (2 papers)Diabetes Obesity and Metabolism (2 papers)
Partner nations: Denmark United States South Africa

In The Last Decade

Søren T. Hoff

35 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial 2019 · 411 citations

Peers

Countries citing papers authored by Søren T. Hoff

Since Specialization

Citations

This map shows the geographic impact of Søren T. Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Søren T. Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Søren T. Hoff more than expected).

Fields of papers citing papers by Søren T. Hoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Søren T. Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Søren T. Hoff. The network helps show where Søren T. Hoff may publish in the future.

Co-authors

The 25 scholars most cited alongside Søren T. Hoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Søren T. Hoff Line = papers co-authored together Søren T. Hoff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) Journal of the American College of Cardiology ·Subodh Verma, Helen M. Colhoun, Dror Dicker, G. Kees Hovingh, Steven E. Kahn, Alexandra Kautzky‐Willer, Ildiko Lingvay, Jorge Plutzky, Sophie Vlaar, Naveen Rathor, Søren T. Hoff, A. Michael Lincoff	2024	11
2	Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6 Diabetes Therapy ·Stephen C. Bain, Brian Newton, Søren T. Hoff, Mansoor Husain, Søren Rasmussen, Tina Vilsbøll, Mark C. Petrie	2024	5
3	Ex vivo mRNA expression of toll-like receptors during latent tuberculosis infection BMC Immunology ·Birhan Alemnew, Søren T. Hoff, Tamrat Abebe, Markos Abebe, Abraham Aseffa, Rawleigh Howe, Liya Wassie	2021	5
4	Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial The Lancet ·Richard E. Pratley, Aslam Amod, Søren T. Hoff, Takashi Kadowaki, Ildiko Lingvay, Michael A. Nauck, Karen Boje Pedersen, Trine Saugstrup, Juris J. Meier Hit paper breakdown →	2019	411
5	Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial American Journal of Respiratory and Critical Care Medicine ·Sara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, Michèle Tameris, Søren T. Hoff, Zhongkai Shi, Dereck Tait, Ingrid Kromann, Morten Rühwald, Kathryn Rutkowski, Barbara Shepherd, David A. Hokey, Ann M. Ginsberg, Willem A. Hanekom, Peter Andersen, Thomas J. Scriba, Mark Hatherill	2018	76
6	A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area Trials ·Jemal Hussein, Martha Zewdie, Lawrence Yamuah, Ahmed Bedru, Markos Abebe, Alemnew F. Dagnew, 李逸君, J.-C. Trone, Santiago Cuéllar, Howard Engers, T. Mark Doherty, Peter Fibiger Bang, Ingrid Kromann, Søren T. Hoff, Abraham Aseffa	2018	21
7	C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial PLoS ONE ·Henrik Aggerbeck, Morten Rühwald, Søren T. Hoff, Pheobe Raymond, Elizabeth Hellström, Mookho Malahleha, 陈为人, ElSayed Allam, Iben Boutrup Kongsfelt, Andreas H. Diacon, Wael M.H. El Shae, Peter Andersen, Keertan Dheda	2018	49
8	Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6 Scientific Reports ·Morten Rühwald, Z. Jiang, A. Davanou, Carrol Jaques, Ahmed M. Salman, G. N. Goryaeva, Davood Hashemabadi, Minas W Gebru, Bolette Søborg, Thomas Blauenfeldt, Stellah Mpagama, Søren T. Hoff, Else Marie Agger, Ida Rosenkrands, Farah Martens, Gibson Kibiki, Esma Özsert, Peter Andersen	2017	16
9	Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials Vaccine ·Nerea Salmón, Timo Vesikari, Jilmar Castañeda-Ccori, Markus Maeurer, Raija Ahmed, Shahnaz Mahdavifar, Sean Bennett, J. Bruce McClain, Barbara Shepherd, Daner Li, David A. Hokey, Ingrid Kromann, Søren T. Hoff, Peter Andersen, Adriëtte W. de Visser, Simone A. Joosten, Tom H. M. Ottenhoff, Jan Andersson, Susanna Brighenti	2017	41
10	The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders PLoS ONE ·Minas W Gebru, Bolette Søborg, Lars Jorge Díaz, Søren T. Hoff, Else Marie Agger, Anders Koch, Ida Rosenkrands, Jan Wohlfahrt, Mads Melbye	2017	9
11	Host immunity to Mycobacterium tuberculosis and risk of tuberculosis: A longitudinal study among Greenlanders Vaccine ·Minas W Gebru, Bolette Søborg, Else Marie Agger, Lars Jorge Díaz, Søren T. Hoff, Anders Koch, Hans Christian Florian Sørensen, Peter Andersen, Jan Wohlfahrt, Mads Melbye	2016	7
12	Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4⁺T Cells Clinical and Vaccine Immunology ·Nicole Lenz, Tobias Schindler, Benjamin M. Kagina, Jitao David Zhang, Yunpeng Dai, Maxmillian Mpina, Peter Fibiger Bang, Ingrid Kromann, Søren T. Hoff, Peter Andersen, Klaus Reither, Gavin Churchyard, Ulrich Certa, Claudia Daubenberger	2015	7
13	The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial Vaccine ·Hennie Geldenhuys, Helen Mearns, David J. C. Miles, Michèle Tameris, David A. Hokey, Zhongkai Shi, Sean Bennett, Peter Andersen, Ingrid Kromann, Søren T. Hoff, Willem A. Hanekom, Hassan Mahomed, Mark Hatherill, Thomas J. Scriba, Michele van Rooyen, J. Bruce McClain, Robert Ryall, Guy de Bruyn	2015	56
14	H1- and H56- subunit vaccines against TB - an overview of the clinical development European Respiratory Journal ·Morten Rühwald, Else Marie Agger, Søren T. Hoff, Peter Andersen	2014	1
15	The effectiveness of BCG vaccination in preventingMycobacterium tuberculosisinfection and disease in Greenland Thorax ·Minas W Gebru, Bolette Søborg, Anders Koch, Lisbeth Carstensen, Søren T. Hoff, Else Marie Agger, Troels Lillebæk, Dr Iuliana Slesari, Jan Wohlfahrt, Mads Melbye	2014	39
16	A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human Vaccine ·Jaap T. van Dissel, Simone A. Joosten, Søren T. Hoff, Darius Soonawala, Corine Prins, David A. Hokey, Dawn M. O’Dee, Andrew J. Graves, Birgit Thierry-Carstensen, Lars Vibe Andreasen, Morten Rühwald, Adriëtte W. de Visser, Else Marie Agger, Tom H. M. Ottenhoff, Ingrid Kromann, Peter Andersen	2014	190
17	Human B cells produce chemokine CXCL10 in the presence of Mycobacterium tuberculosis specific T cells Tuberculosis ·Søren T. Hoff, Ahmed M. Salman, Morten Rühwald, Pernille Ravn, Inger Brock, Esma Özsert, Peter Andersen, Else Marie Agger	2014	13
18	Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3: A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial PLoS ONE ·Klaus Reither, 沈权民, Anthony V. Hoots, Steven E. Johnston, Nicole Lenz, Khadija Said, Elirehema Mfinanga, D. Law, Katherine Fielding, Masaru Negoro, Benjamin M. Kagina, E. Jane Hughes, Thomas J. Scriba, Willem A. Hanekom, Søren T. Hoff, Peter Fibiger Bang, Ingrid Kromann, Claudia Daubenberger, Peter Andersen, Gavin Churchyard	2014	49
19	First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent PLoS ONE ·فاطمة محمد عليمات, Pernille N. Tingskov, Birgit Thierry-Carstensen, Søren T. Hoff, Henrik Aggerbeck, Vibeke Østergaard Thomsen, Peter Andersen, Åse Bengård Andersen	2010	29
20	Identification of Rv0222 from RD4 as a novel serodiagnostic target for tuberculosis Tuberculosis ·Ida Rosenkrands, Claus Aagaard, Karin Weldingh, Inger Brock, Morten Hanefeld Dziegiel, Mahavir Singh, Søren T. Hoff, Pernille Ravn, Peter Andersen	2008	33

About Søren T. Hoff

Søren T. Hoff is a scholar working on Infectious Diseases, Immunology, Endocrinology, Diabetes and Metabolism, Epidemiology and Virology, having authored 35 papers that have together received 2.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (24 papers), Mycobacterium research and diagnosis (12 papers), Immunodeficiency and Autoimmune Disorders (9 papers), Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (7 papers), vaccines and immunoinformatics approaches (6 papers), Infectious Diseases and Tuberculosis (5 papers) and Pharmacology and Obesity Treatment (3 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Immunology (1.2k citations), Virology (142 citations), Endocrinology, Diabetes and Metabolism (498 citations) and Epidemiology (909 citations). Søren T. Hoff has collaborated with scholars based in Denmark, United States and South Africa. Frequent co-authors include Peter Andersen, Mario Roederer, Robert A. Seder, Ross Lindsay, Barbara J. Flynn, Steven G. Reed, Dylan Davey, Patricia A. Darrah, Sheldon L. Morris and Paula Mello De Luca. Their work appears in journals such as PLoS ONE, Vaccine, Tuberculosis, European Respiratory Journal and Diabetes Obesity and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact